Too Much Weight Loss With Retatrutide? Transgender Doc Sued; Ice Age Growth Disorder

(MedPage Today) — Some participants in a weight-loss trial of retatrutide, an investigational triple-hormone receptor agonist, dropped out because they thought they were losing too much weight. (New York Times)
Meanwhile, UBT251, another investigational…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/120024

Author :

Publish date : 2026-02-24 19:55:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Too Much Weight Loss With Retatrutide? Transgender Doc Sued; Ice Age Growth Disorder

Checking the Facts on Trump’s Claims About Healthcare Issues in Greenland

Price Controls ‘Inevitable’ in U.S. Healthcare, Economist Says

Related Posts

Brokers Get Paid More to Enroll Seniors in Medicare Advantage. Is That a Problem?

A Simple Test Could Predict a Patient’s Final 24 Hours

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Is a super El Niño imminent, and what could the impacts be?

Brain Atrophy and Circadian Rhythms; New Fluoride and IQ Data; Autism Brain Donation

Are Medical Errors Driven by Systems Rather Than Clinicians?

Brokers Get Paid More to Enroll Seniors in Medicare Advantage. Is That a Problem?

A Simple Test Could Predict a Patient’s Final 24 Hours

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Is a super El Niño imminent, and what could the impacts be?

Brain Atrophy and Circadian Rhythms; New Fluoride and IQ Data; Autism Brain Donation

Are Medical Errors Driven by Systems Rather Than Clinicians?

Aortic Arch Stent Graft OK’d; AI Cardiac Tool Lawsuit; Mining Head CTs for CVD Risk

Meal Monotony for Weight Loss; Genes Explain GLP-1 Response; Menopause Drug Boom

Categories

Archives